Related Experiment Video

Updated: Jun 4, 2026

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts
06:06

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts

Published on: December 20, 2024

p95HER2 and breast cancer

Joaquín Arribas1, José Baselga, Kim Pedersen

  • 1Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. jarribas@vhio.net

Cancer Research
|February 24, 2011
PubMed

Insights

The HER2-positive breast cancer subtype expressing p95HER2 fragments is linked to poor prognosis. This fragment drives tumor progression and predicts resistance to trastuzumab therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • HER2-positive breast cancer is a significant subtype.
  • A specific variant involves carboxy-terminal fragments known as p95HER2.
  • These fragments possess distinct biological and clinical characteristics.

Purpose of the Study:

  • To investigate the role of p95HER2 in breast cancer progression.
  • To understand the clinical implications of p95HER2 expression.
  • To evaluate the association between p95HER2 and trastuzumab resistance.

Main Methods:

  • Utilized specific anti-p95 antibodies for detection.
  • Analyzed the biological activity of p95HER2 fragments, including homodimerization.
  • Correlated p95HER2 expression with clinical outcomes and treatment response.

Main Results:

  • Identified a 100- to 115-kDa p95HER2 fragment (611-CTF) that forms hyperactive homodimers.
  • Demonstrated that p95HER2 drives breast cancer progression in vivo despite lacking most of the extracellular domain.
  • Confirmed that p95HER2 expression predicts poor prognosis and resistance to trastuzumab.

Conclusions:

  • p95HER2 represents a key driver in a subset of HER2-positive breast cancers.
  • The presence of p95HER2 indicates a more aggressive tumor biology.
  • p95HER2 expression serves as a predictive biomarker for trastuzumab treatment failure.

More Related Videos

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...